MENDY HICKS: Open Payments
NPI 1205180585 · MURFREESBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,920 in 97 payments from 25 companies in 2025. Trend: 2023 $1,505 · 2024 $1,864 · 2025 $1,920
Food & beverage: $1,920
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $247 |
| PFIZER INC. | 10 | $181 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $132 |
| GlaxoSmithKline, LLC. | 6 | $130 |
| Antares Pharma, Inc. | 6 | $115 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $113 |
| Lilly USA, LLC | 10 | $112 |
| Otsuka America Pharmaceutical, Inc. | 4 | $96 |
| Lundbeck LLC | 4 | $94 |
| Novartis Pharmaceuticals Corporation | 3 | $93 |
Products named: CAPLYTA, SHINGRIX, REXULTI, NURTEC ODT, XYOSTED, XIFAXAN, LEQVIO, Veozah.
Industry payments across TN — which companies pay providers there.
